middle.news
Next Science Completes $50M Asset Sale, Eyes $30M Return to Shareholders
8:32am on Tuesday 16th of September, 2025 AEST
•
Healthcare
Read Story
Next Science Completes $50M Asset Sale, Eyes $30M Return to Shareholders
8:32am on Tuesday 16th of September, 2025 AEST
Key Points
Completion of asset sale to OSARTIS GmbH for US$50 million
Estimated net proceeds of around US$30 million after costs and liabilities
Next Science to hold shareholder meeting to approve distribution method
Transitional service agreements in place until end of 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NXS
OPEN ARTICLE